NCT00608517 · FLOW

Participant flow

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil · Source last updated 2014-05-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

description
Patients undergo total-body irradiation on days -7 to -4, and receive cyclophosphamide intravenous (IV) over 1 hour on days -3 and -2, methylprednisolone IV twice daily on days -3 to -1, and anti-thymocyte globulin IV over 4 hours on days -3 to -1.
id
FG000
title
Pediatric Myeloablative Conditioning
description
Patients receive fludarabine phosphate intravenous (IV) over 30 minutes on days -6 to -4, cyclophosphamide IV over 1 hour on days -5 and -4, and undergo total-body irradiation on days -3 to -1.
id
FG001
title
Adult Myeloablative Conditioning
description
Patients receive fludarabine phosphate intravenous (IV) over 30 minutes on days -6 to -2 and cyclophosphamide IV over 1 hour on day -6 and undergo total-body irradiation on day -1.
id
FG002
title
Reduced-intensity Conditioning

periods

drop Withdraws
reasons
group Id
FG000
num Subjects
1
group Id
FG001
num Subjects
0
group Id
FG002
num Subjects
0
type
Death
milestones
achievements
group Id
FG000
num Subjects
2
group Id
FG001
num Subjects
3
group Id
FG002
num Subjects
1
type
STARTED
achievements
group Id
FG000
num Subjects
1
group Id
FG001
num Subjects
3
group Id
FG002
num Subjects
1
type
COMPLETED
achievements
group Id
FG000
num Subjects
1
group Id
FG001
num Subjects
0
group Id
FG002
num Subjects
0
type
NOT COMPLETED
title
Overall Study

pre Assignment Details

A total of 7 people signed consent to take part in this study. Of those, 1 was determined to be ineligible.

recruitment Details

Recruitment period = 9/23/2005 through 8/15/2008

Complete source fields